| The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma W Sieghart, F Hucke, M Pinter, I Graziadei, W Vogel, C Müller, H Heinzl, ... Hepatology 57 (6), 2261-2273, 2013 | 382 | 2013 |
| Transarterial chemoembolization: modalities, indication, and patient selection W Sieghart, F Hucke, M Peck-Radosavljevic Journal of hepatology 62 (5), 1187-1195, 2015 | 322 | 2015 |
| Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib M Pinter, F Hucke, I Graziadei, W Vogel, A Maieron, R Königsberg, ... Radiology 263 (2), 590-599, 2012 | 226 | 2012 |
| How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma F Hucke, M Pinter, I Graziadei, S Bota, W Vogel, C Mueller, H Heinzl, ... Journal of hepatology 61 (6), 1287-1296, 2014 | 181 | 2014 |
| The ART-strategy: sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE F Hucke, W Sieghart, M Pinter, I Graziadei, W Vogel, C Müller, H Heinzl, ... Journal of Hepatology 60 (1), 118-126, 2014 | 153 | 2014 |
| Single determination of Creactive protein at the time of diagnosis predicts longterm outcome of patients with hepatocellular carcinoma W Sieghart, M Pinter, F Hucke, I Graziadei, M SchönigerHekele, C Müller, ... Hepatology 57 (6), 2224-2234, 2013 | 128 | 2013 |
| Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib M Pinter, W Sieghart, F Hucke, I Graziadei, W Vogel, A Maieron, ... Alimentary pharmacology & therapeutics 34 (8), 949-959, 2011 | 87 | 2011 |
| Clinical characteristics of patients with hepatocellular carcinoma in Austria-is there a need for a structured screening program? F Hucke, W Sieghart, M Schöniger-Hekele, M Peck-Radosavljevic, ... Wiener klinische Wochenschrift 123, 2011 | 71 | 2011 |
| Association of platelet count and mean platelet volume with overall survival in patients with cirrhosis and unresectable hepatocellular carcinoma B Scheiner, M Kirstein, S Popp, F Hucke, S Bota, N Rohr-Udilova, ... Liver Cancer 8 (3), 203-217, 2019 | 63 | 2019 |
| Use of inhibitors of the renin–angiotensin system is associated with longer survival in patients with hepatocellular carcinoma M Pinter, A Weinmann, MA Wörns, F Hucke, S Bota, JU Marquardt, ... United European gastroenterology journal 5 (7), 987-996, 2017 | 56 | 2017 |
| Incidence and mortality trends for biliary tract cancers in Austria M Pinter, F Hucke, N Zielonke, T Waldhör, M Trauner, ... Liver international 34 (7), 1102-1108, 2014 | 39 | 2014 |
| The impact of thyroid hormones on patients with hepatocellular carcinoma M Pinter, L Haupt, F Hucke, S Bota, T Bucsics, M Trauner, ... PloS one 12 (8), e0181878, 2017 | 35 | 2017 |
| Differentiation of intrahepatic cholangiocellular carcinoma from hepatocellular carcinoma in the cirrhotic liver using contrast-enhanced MR imaging GJ Wengert, PAT Baltzer, H Bickel, P Thurner, J Breitenseher, M Lazar, ... Academic Radiology 24 (12), 1491-1500, 2017 | 17 | 2017 |
| Epidemiological trends of hepatocellular carcinoma in Austria M Pinter, F Hucke, N Zielonke, M Trauner, W Sieghart, ... Digestive Diseases 32 (6), 664-669, 2014 | 17 | 2014 |
| Validation of the BCLC-B subclassification in an Austrian TACE cohort F Hucke, M Pinter, I Graziadei, W Vogel, M Trauner, W Sieghart, ... Zeitschrift für Gastroenterologie 52 (05), P70, 2014 | 1 | 2014 |
| Prognostic impact of the BAVENO IV staging system of portal hypertension in patients with cirrhosis and hepatocellular carcinoma E Pachta, F Hucke, S Weiss, S Popp, L Haupt, M Peck-Radosavljevic, ... Zeitschrift für Gastroenterologie 52 (05), P72, 2014 | 1 | 2014 |
| Prognostic validation of the BCLC-B subclassification in an Austrian TACE cohort F Hucke, I Graziadei, W Vogel, M Peck-Radosavljevic, W Sieghart WIENER KLINISCHE WOCHENSCHRIFT 126 (17-18), 566-567, 2014 | | 2014 |
| Validation of the Hong Kong Liver Cancer (HKLC) staging system in a Western cohort of patients with Hepatocellular Carcinoma F Hucke, S Bota, M Pinter, M Peck-Radosavljevic, W Sieghart WIENER KLINISCHE WOCHENSCHRIFT 126 (17-18), 567-567, 2014 | | 2014 |
| TRANSARTERIAL (CHEMO-) EMBOLIZATION VERSUS SORAFENIB IN PATIENTS WITH ADVANCED STAGE HEPATOCELLULAR CARCINOMA: 2190 M Pinter, F Hucke, I Graziadei, A Maieron, R Königsberg, RE Stauber, ... Hepatology 54 (4), 1388A, 2011 | | 2011 |
| Outcome of patients with Child-Pugh C liver cirrhosis and hepatocellular carcinoma after liver transplantation W Sieghart, M Pinter, I Graziadei, F Hucke, S Rasoul-Rockenschaub, ... Zeitschrift für Gastroenterologie 49 (05), P10, 2011 | | 2011 |
